Erythropoietin resistance contributes to anaemia in chronic heart failure and relates to aberrant JAK-STAT signal transduction

International Journal of Cardiology

Volumn 164, Issue 3, 2013, Pages 359-364

  Okonko, Darlington O ^a   Marley, Stephen B ^b   Anker, Stefan D ^a   Poole Wilson, Philip A ^a   Gordon, Myrtle Y ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Anaemia; Erythropoietin resistance; Heart failure

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; JANUS KINASE; STAT PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; CD36 ANTIGEN; CREATININE; FERRITIN; HEMOGLOBIN; IRON; STAT5 PROTEIN; TRANSFERRIN; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ANEMIA; ARTICLE; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG TARGETING; ERYTHROBLAST; ERYTHROID PRECURSOR CELL; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; HEART FAILURE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; BLOOD SAMPLING; COLONY FORMATION; DOWN REGULATION; DRUG RESPONSE; ERYTHROID CELL; HEART LEFT VENTRICLE EJECTION FRACTION; IRON BLOOD LEVEL; MONOCYTE; PROTEIN FUNCTION; RETICULOCYTE COUNT;

AGED; ANEMIA; CELLS, CULTURED; CHRONIC DISEASE; DOWN-REGULATION; DRUG RESISTANCE; ERYTHROID PRECURSOR CELLS; ERYTHROPOIETIN; FEMALE; FLOW CYTOMETRY; HEART FAILURE; HUMANS; JANUS KINASES; MALE; MIDDLE AGED; RECEPTORS, ERYTHROPOIETIN; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR;

EID: 84884213329     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.07.045     Document Type: Article

References (34)

1. J.W. Fisher Erythropoietin: physiology and pharmacology update Exp Biol Med (Maywood) 228 2003 1 14
2. H. Youssoufian, G. Longmore, D. Neumann, A. Yoshimura, and H.F. Lodish Structure, function, and activation of the erythropoietin receptor Blood 81 1993 2223 2236
3. D.M. Wojchowski, R.C. Gregory, C.P. Miller, A.K. Pandit, and T.J. Pircher Signal transduction in the erythropoietin receptor system Exp Cell Res 253 1999 143 156
4. -/- mice: a direct role for Stat5 in Bcl-X(L) induction Cell 98 1999 181 191
5. H. Wu, X. Liu, R. Jaenisch, and H.F. Lodish Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor Cell 83 1995 59 67
6. H. Neubauer, A. Cumano, M. Muller, H. Wu, U. Huff-Stadt, and K. Pfeffer Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis Cell 93 1998 397 409
7. M.P. Menon, V. Karur, O. Bogacheva, O. Bogachev, B. Cuetara, and D.M. Wojchowski Signals for stress erythropoiesis are integrated via an erythropoietin receptor-phosphotyrosine-343-Stat5 axis J Clin Invest 116 2006 683 694
8. M. Volpe, C. Tritto, and U. Testa Blood levels of erythropoietin in congestive heart failure and correlation with clinical, hemodynamic, and hormonal profiles Am J Cardiol 74 1994 468 473
9. P. van der Meer, D.J. Lok, and J.L. Januzzi Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients Eur Heart J 29 2008 1510 1515
10. C. Adlbrecht, S. Kommata, and M. Hulsmann Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volume Eur Heart J 29 2008 2343 2350
11. Y.D. Tang, and S.D. Katz Anaemia in chronic heart failure: prevalence, aetiology, clinical correlates, and treatment options Circulation 113 2006 2454 2461
12. I.C. Macdougall, and A.C. Cooper Hyporesponsiveness to erythropoietic therapy due to chronic inflammation Eur J Clin Invest 35 2005 32 35
13. A. Dowlati, S. R'Zik, G. Fillet, and Y. Beguin Anaemia of lung cancer is due to impaired erythroid marrow response to erythropoietin stimulation as well as relative inadequacy of erythropoietin production Br J Haematol 97 1997 297 299
14. K. Swedberg, J. Cleland, and H. Dargie Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology Eur Heart J 26 2005 1115 1140
15. R.S. Riley, J.M. Ben-Ezra, R. Goel, and A. Tidwell Reticulocytes and reticulocyte enumeration J Clin Lab Anal 15 2001 267 294
16. C. Opasich, M. Cazzola, and L. Scelsi Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure Eur Heart J 26 2005 2232 2237
17. I. Theurl, V. Mattle, M. Seifert, M. Mariani, C. Marth, and G. Weiss Dysregulated monocyte iron homeostasis and erythropoietin formation in patients with anaemia of chronic disease Blood 107 2006 4142 4148
18. L.L. Kelley, M.J. Koury, M.C. Bondurant, S.T. Koury, S.T. Sawyer, and A. Wickrema Survival or death of individual proerythroblasts results from differing erythropoietin sensitivities: a mechanism for controlled rates of erythrocyte production Blood 82 1993 2340 2352
19. S.D. Anker, M. Volterrani, and C.D. Pflaum Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone J Am Coll Cardiol 38 2001 443 452
20. J.W. Swan, S.D. Anker, and C. Walton Insulin resistance in chronic heart failure: relation to severity and aetiology of heart failure J Am Coll Cardiol 30 1997 527 532
21. D.A. Allen, C. Breen, M.M. Yaqoob, and I.C. Macdougall Inhibition of CFU-E colony formation in uremic patients with inflammatory disease: role of IFN-gamma and TNF-alpha J Investig Med 47 1999 204 211
22. M. Jongen-Lavrencic, H.R. Peeters, B. Backx, I.P. Touw, G. Vreugdenhil, and A.J. Swaak R-h- erythropoietin counteracts the inhibition of in vitro erythropoiesis by tumour necrosis factor alpha in patients with rheumatoid arthritis Rheumatol Int 14 1994 109 113
23. S. Taniguchi, C.H. Dai, J.O. Price, and S.B. Krantz Interferon gamma downregulates stem cell factor and erythropoietin receptors but not insulin-like growth factor-I receptors in human erythroid colony-forming cells Blood 90 1997 2244 2252
24. P.A. Tilbrook, T. Bittorf, B. Callus, S.J. Busfield, E. Ingley, and S.P. Klinken Regulation of the erythropoietin receptor and involvement of JAK2 in differentiation of J2E erythroid cells Cell Growth Differ 28 1996 175 181
25. D.C.H. Ng, N.W. Court, C.G. dos Remedios, and M.A. Bogoyevitch Activation of signal transducer and activator of transcription (STAT) pathways in failing human hearts Cardiovasc Res 57 2003 333 346
26. M. Buitenhuis, P.J. Coffer, and L. Koenderman Signal transducer and activator of transcription 5 (STAT5) Int J Biochem Cell Biol 36 2004 2120 2124
27. D. Guo, J.D. Dunbar, C.H. Yang, L.M. Pfeffer, and D.B. Donner Induction of Jak/STAT signaling by activation of the type 1 TNF receptor J Immunol 160 1998 2742 2750
28. L. Fernández, A. Flores-Morales, and O. Lahuna Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C Endocrinology 139 1998 1815 1824
29. C.A. Gebert, S. Park, and D.J. Waxman Regulation of signal transducer and activator of transcription (STAT) 5b activation by the temporal pattern of growth hormone stimulation Mol Endocrinol 11 1997 400 414
30. P. Wang, N. Li, J.S. Li, and W.Q. Li The role of endotoxin, TNF-alpha, and IL-6 in inducing the state of growth hormone insensitivity World J Gastroenterol 8 2002 531 536
31. U. Klingmüller, U. Lorenz, L.C. Cantley, B.G. Neel, and H.F. Lodish Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals Cell 80 1995 729 738
32. S. Akagi, H. Ichikawa, and T. Okada The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anaemia in chronic hemodialysis patients J Am Soc Nephrol 15 2004 3215 3224
33. B.D. Westenbrink, A.A. Voors, and R.A. de Boer Bone marrow dysfunction in chronic heart failure patients Eur J Heart Fail 12 2010 676 684
34. W.P. Ruifrok, C. Qian, and H.H. Silljé Heart failure-associated anaemia: bone marrow dysfunction and response to erythropoietin J Mol Med 89 2011 377 387